Mumbai, Nov. 18 -- The scrip was listed at Rs 116, a premium of 1.75% over the initial public offer (IPO) price. The stock is currently frozen at its lower limit of 5% over its listing price.

The counter hit a high of Rs 121.80 and a low of Rs 115.50. About 18.98 lakh shares of the company changed hands at the counter.

Mahamaya Lifesciences's IPO was subscribed 1.59 times. The issue opened for bidding on 11 November 2025 and it closed on 13 October 2025. The price band of the IPO was fixed between Rs 108 to Rs 114 per share.

The IPO comprised 61,78,800 equity shares, including a fresh issue of 56,38,800 equity shares and offer for sale (OFS) of 5,40,000 equity shares. The promoter and promoter group shareholding diluted to 56.35% from ...